1. Adelaide Research & Scholarship

Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 10 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Glucagon-like peptides 1 and 2 in health and disease: A reviewMarathe, C.; Rayner, C.; Jones, K.; Horowitz, M.
2014Incretins and the intensivist: what are they and what does an intensivist need to know about them?Plummer, M.; Chapman, M.; Horowitz, M.; Deane, A.
2014Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans and patients with type 2 diabetes treated with or without metforminWu, T.; Ma, J.; Bound, M.; Checklin, H.; Deacon, C.; Jones, K.; Horowitz, M.; Rayner, C.
2019Comparative effects of proximal and distal small intestinal glucose exposure on glycemia, incretin hormone secretion, and the incretin effect in health and type 2 diabetesZhang, X.; Young, R.L.; Bound, M.; Hu, S.; Jones, K.L.; Horowitz, M.; Rayner, C.K.; Wu, T.
2015Hyperglycemia potentiates the slowing of gastric emptying induced by exogenous GLP-1Plummer, M.; Jones, K.; Cousins, C.; Trahair, L.; Meier, J.; Chapman, M.; Horowitz, M.; Deane, A.
2016A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetesWu, T.; Little, T.; Bound, M.; Borg, M.; Zhang, X.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.
2013Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetesWu, T.; Bound, M.; Zhao, R.; Standfield, S.; Bellon, M.; Jones, K.; Horowitz, M.; Rayner, C.
2013Effects of intraduodenal glutamine on incretin hormone and insulin release, the glycemic response to an intraduodenal glucose infusion, and antropyloroduodenal motility in health and type 2 diabetesChang, J.; Wu, T.; Greenfield, J.; Samocha-Bonet, D.; Horowitz, M.; Rayner, C.
2011Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetesDeane, A.; Summers, M.; Zaknic, A.; Chapman, M.; Fraser, R.; Di Bartolomeo, A.; Wishart, J.; Horowitz, M.
2011Effects of GLP-1 and incretin-based therapies on gastrointestinal motor functionMarathe, C.; Rayner, C.; Jones, K.; Horowitz, M.

Discover